A research group at the
The article examines the use of UCNPs to distinguish different levels of HER2 in CPA (control pellet arrays) and HER2-positive breast cancer tissue. The results demonstrate a good semi-quantitative tool for assessing HER2 in breast cancer tissues.
- It is very positive that our technology is being tested in different types of applications, and we are pleased that the results in the article are promising compared to traditional reference methods, comments CEOMattias Lundin .
The article is published here: https://opg.optica.org/boe/fulltext.cfm?uri=boe-15-2-900&id=545726
© Modular Finance, source